Top AcceleTrial Alternatives

Castor is an innovative clinical trial platform designed to simplify data management through electronic data capture (EDC), eConsent, and patient-reported outcomes (ePRO). Its flexible and user-friendly interface allows researchers to collect, manage, and analyze clinical data efficiently across multiple sites and remote patients. Castor’s tools are specifically designed to support decentralized clinical trials (DCTs), enabling real-time data monitoring, remote recruitment, and seamless patient engagement. The platform ensures full regulatory compliance, including HIPAA, GDPR, and 21 CFR Part 11, and is certified for ISO standards. With more than 50,000 global users, Castor continues to improve the speed and quality of clinical trials through integrated, scalable solutions that reduce administrative burdens and accelerate research.

The complexity of Modern Interactive Response Technology (IRT) systems is on the rise. The importance of customizable and adaptable IRT solutions is paramount, as these systems are crucial for gathering vital information such as recruitment statistics, clinical trial dropout rates, and patient participation. Choosing a user-friendly, mobile-optimized, and comprehensive platform is essential, built on a foundation of quality, flexibility, and expertise. It is essential to engage with a partner that possesses deep therapeutic insights relevant to today’s risk-based eClinical environment. By integrating state-of-the-art technology with specialized expertise and a commitment to outstanding service, we significantly improve clinical trials, ultimately leading to better patient outcomes. Our profound knowledge of clinical workflows and supply chain intricacies drives innovation, empowering clients with enhanced control over their Randomization and Trial Supply Management (RTSM) processes. Our revolutionary tools not only boost quality assurance but also substantially increase site efficiency and patient adherence. Additionally, our versatile IRT platform is designed to accommodate a diverse range of studies and can achieve complete validation and deployment within just 30 days, thereby optimizing clinical trial procedures. This rapid rollout facilitates quicker data acquisition and contributes to a more streamlined overall trial management experience, ultimately paving the way for more effective clinical research outcomes.

Since 2005, Medrio's Electronic Data Capture (EDC) platform and its complementary eClinical solutions like ePRO, RTSM, eConsent, and Direct Data Capture (DDC) have gained the trust of leading pharmaceutical, biotech, CRO, animal health, medical device, and diagnostic organizations. Our reputation is built on providing user-friendly solutions that enhance the efficiency and simplicity of clinical trials across all phases, sizes, and complexities. Users of Medrio can create their databases in an average of 2.8 weeks without needing any programming skills and can easily implement mid-study modifications with just a few clicks. With options ranging from add-on features to comprehensive service packages, Medrio delivers adaptable, modular solutions tailored to meet the precise needs of our clients, ensuring they receive only the services they require. Our cutting-edge software, combined with extensive training and support resources, has resulted in a remarkable 98% customer satisfaction rating, demonstrating our commitment to excellence in the clinical trial landscape. We continuously strive to innovate and improve our offerings to keep pace with the evolving needs of our users.

Suvoda stands as a prominent player in the arena of clinical trial technology, concentrating on complex, life-saving research in areas such as oncology, central nervous system disorders, and rare diseases. Founded in 2013, the organization offers a robust platform equipped with Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all designed to optimize critical patient engagements. Their cutting-edge software ensures a seamless user experience, facilitating precise randomization, effective drug supply management, and prompt data gathering. Committed to enhancing patient comprehension and reducing the burdens faced by trial sites, Suvoda's solutions are crafted to adapt to the growing intricacies of clinical research. Headquartered near Philadelphia, with additional branches throughout Europe and Asia, Suvoda has proudly aided in the execution of over 1,500 trials across more than 85 countries, demonstrating their extensive global influence and proficiency in the industry. Their unwavering focus on innovation and high standards establishes them as an essential ally in the progress of clinical research, paving the way for future breakthroughs and transformations in the field.

VIPER enhances the screening process by automating the identification of remote patients at the diagnosis phase, thereby ensuring that qualified candidates are enrolled. Utilizing artificial intelligence, the system adeptly aligns patients with precision trials during a vital enrollment window, drawing on lab-agnostic genomic data, electronic medical records (EMR), and pathology data that cater to individual patient profiles and specific research demands. The specialized matching engine rigorously searches for the most appropriate clinical trials that correlate with a patient's diagnosis as soon as it is made. Moreover, VIPER integrates seamlessly into existing workflows, providing real-time notifications about patient eligibility for ongoing trials, which keeps the entire healthcare team informed during this critical period. In addition to these features, VIPER incorporates interactive dashboards that facilitate extensive data mining, enabling the collection and analysis of site and study-level patient information to effectively achieve study key performance indicators (KPIs). This holistic strategy not only boosts the efficiency of trial recruitment but also significantly aids researchers in reaching their objectives with greater success. By continuously refining its processes, VIPER stands to further revolutionize the landscape of clinical trial enrollment.

The BizNET-CTM suite provides a robust solution for managing clinical trials, catering to diverse industries such as Contract Research Organizations (CROs), pharmaceuticals, biotechnology, and medical devices. This adaptable platform enables CROs to proficiently plan, oversee, design, implement, monitor, and analyze all facets of clinical trials while adhering to protocol requirements and regulatory guidelines. It encompasses the full spectrum of the clinical research project lifecycle, starting from project management and feasibility evaluations, moving to patient or volunteer enrollment facilitated by advanced iris recognition technology, and including the collection of trial data. A multi-layered review process is integrated into the platform, along with data compilation and subsequent archiving, ensuring comprehensive oversight throughout. Additionally, the BizNET-CTM suite is meticulously designed to manage all essential documents, tasks, processes, relationships, audits, and training required during a clinical trial, thereby optimizing operations and boosting efficiency in clinical research. This forward-thinking approach not only simplifies intricate processes but also significantly improves the accuracy and dependability of trial results, leading to better-informed decisions in the ever-evolving landscape of clinical research. Ultimately, the suite stands as a pivotal resource in advancing the effectiveness of clinical trials across various sectors.

The Clinion Clinical Trial Management System (CTMS) offers an intuitive interface that integrates effortlessly with Clinion EDC and Clinion RTSM, providing rapid and thorough access to all elements of the trial process, thereby managing critical aspects such as investigator sites, patient enrollment, serious adverse events (SAEs), protocol deviations, participant inclusions, visit scheduling, investigational product (IP) management, key milestones, financial oversight, custom reporting, and real-time analytics, which collectively enhance quality, mitigate risks, and lower expenses. Designed with a modular architecture, Clinion CTMS includes a variety of modules tailored for specific needs, such as the Admin Module, Project Management, Site Monitoring Activities, Finance and Budget Management, Safety Reporting, IP Inventory Management, Document Management System, Audit/Activity Log, and provides comprehensive dashboards and reports to facilitate efficient trial oversight.

Research teams are increasingly pressured to deliver improved results despite constraints in resources. The advancement of a clinical trial can be greatly obstructed by challenges such as uncoordinated systems, the need for manual data entry, repetitive processes, and scattered information. Therefore, it is crucial to implement a clinical trial management system that effectively integrates and streamlines workflows while providing full transparency; Medidata presents an ideal solution for this need. Rave CTMS is distinguished as the only data-centric platform crafted for efficient and intelligent management of the entire trial process. As an integral part of the Medidata Rave Clinical CloudTM, it includes all the essential features expected from a leading CTMS, along with additional functionalities. With Rave CTMS, your study teams gain the capability to plan and execute all clinical trials in a consistent and unified manner, standardizing activity planning and management at study, country, and site levels. This system facilitates the organization of study/site team creation and activation, tracks patient enrollment and milestones, monitors site performance, and addresses challenges effectively. Furthermore, Rave CTMS fosters improved collaboration and communication among team members, ultimately contributing to more successful trial outcomes, and ensuring that every aspect of the trial is managed with precision and clarity.

Lindus Health is revolutionizing clinical trials by offering a comprehensive solution that delivers faster and more trustworthy results. Our integrated approach merges full-service CRO capabilities, effective site management, and advanced technology to enhance every aspect of your research, from the initial design phase to the ultimate delivery of data. By leveraging our agile in-house technology, we streamline site setup and patient recruitment, utilizing a rich database of over 30 million electronic health records to expedite the enrollment process. Our transparent pricing structure, based on fixed milestones and pay-on-results, effectively aligns our goals with those of our clients, eliminating the possibility of unexpected costs and delays. With an outstanding average satisfaction rating of 9.7 out of 10, our skilled and committed clinical operations team strives for excellence at each step of the process. In a short span of time, Lindus Health has expanded its global presence, successfully managing over 91 trials in various therapeutic fields, including metabolic health, women's health, diagnostics, and medical devices, all while upholding a strong emphasis on innovation and quality in clinical research. This unwavering commitment to efficiency and reliability solidifies Lindus Health’s position as an industry leader, ensuring that we continue to push the boundaries of what is possible in clinical trials. By prioritizing both patient experience and research integrity, we aim to set new standards that will benefit the future of healthcare.

AssisTek emerges as a leader in advanced clinical technology solutions specifically designed for clinical research, offering specialized software that enhances the process of collecting patient data. With a rich history spanning over 25 years, the organization has successfully supported more than 800 clinical research trials across 46 therapeutic areas, including over 500 multinational Phase I–IV trials. Their electronic Clinical Outcome Assessment (eCOA) solutions are marked by scalability, customization, and efficiency, all powered by a dependable cloud-based technology platform. Among their diverse range of products are the TEK eCOA Tablet, adaptable for any questionnaire used in clinical trials, TEK eDiary, which allows for the collection of patient-reported outcomes from home, TEK Configurator for thorough project development in clinical trials, and TEK Study Portal, which integrates eClinical tracking, training, and reporting into a single, user-friendly platform. AssisTek's pioneering systems and services have made them the go-to partner for data collection and analytics, earning the confidence of both patients and healthcare professionals. As they innovate further, AssisTek continues to focus on improving the effectiveness and precision of clinical research methodologies while exploring new avenues to advance the field. Their commitment to excellence ensures they stay at the forefront of technological advancements in clinical research.

ArcheMedX offers a solution designed for pharmaceutical and biotech trusts to enhance the effectiveness of their trial teams, streamline decision-making processes, and minimize delays in studies. By identifying the most capable sites and teams for conducting trials, organizations can sidestep common pitfalls that lead to study postponements. This approach not only cuts down on the time and expenses associated with problem resolution, particularly in the early phases of a trial, but also ensures that selected sites have a thorough understanding of patient eligibility criteria. Consequently, you can trust that they are better positioned to enroll suitable patients more efficiently, achieve enrollment goals, and reduce screen failure rates. Additionally, the trial team’s deep familiarity with the study protocol and its specific objectives fosters a comprehensive understanding of the project. This proactive strategy allows for the anticipation of potential risks, enabling teams to mitigate them effectively and ultimately resulting in fewer deviations throughout the trial process. Overall, this systematic preparation leads to a smoother and more successful trial execution.

Zelta serves as a cloud-based platform dedicated to the unified management and acquisition of clinical data, aiming to optimize and improve the processes involved in clinical trials. Its flexible modular structure is tailored to meet the specific requirements of different studies, which leads to quicker and more effective results. With features that include electronic data capture, management of clinical operations—such as randomization and tracking of trial supplies—clinical trial oversight, and electronic trial master file capabilities, Zelta provides thorough supervision of studies. Additionally, it fosters engagement among patients and providers through electronic clinical outcome assessments and e-consent options. Suitable for a range of studies across all phases, therapeutic disciplines, and international locations, Zelta is designed to offer a user-friendly experience with secure single sign-on access available from any location. Its adaptable and scalable framework permits easy customization and seamless integration with both proprietary and third-party technologies, ensuring it can meet various research requirements effectively. This makes Zelta an invaluable tool for researchers looking to streamline their clinical trial efforts.

ClinSoft™, created internally by Innovate Research, does not involve any external acquisitions or integrations. The software adheres to FDA regulations, including 21 CFR Part 11, GCP, and HIPAA standards, ensuring it is both fully auditable and validated. This user-friendly system facilitates rapid start-up and close-out processes, allowing you to save valuable time and guaranteeing that any amendments or updates to study protocols are implemented efficiently. As a contract research organization based in India, Innovate Research specializes in clinical research and regulatory affairs, ensuring compliance with US FDA 21 CFR Part 11. The platform features secure electronic signatures and records, role-based access control, and an audit trail. Moreover, it includes an intuitive interface for editing checks and setting up case report forms (CRFs), along with reusable frameworks for items, panels, visits, and pages, enhancing usability and efficiency for clinical trials. Additionally, the comprehensive design of ClinSoft™ supports streamlined workflows, ultimately improving overall productivity in clinical research operations.

We develop cutting-edge solutions designed to improve and fortify the clinical trial landscape. Our Enrollment Performance Management platform is preferred by research sites and trusted by sponsors alike. Currently, it is employed by 2,000 research sites across 26 nations and is endorsed by 50% of the world’s leading biopharmaceutical firms. This system allows sites to minimize the time dedicated to repetitive tasks, resulting in smoother patient transitions. By reducing redundant activities, there is a decrease in the number of logs, calls, and emails needed from both research sites and sponsors. With immediate access to detailed pre-screening and enrollment metrics, sponsors can take proactive measures to enhance enrollment efforts. Our highly intuitive patient recruitment and enrollment solution is relied upon by more than 1,800 sites globally. It offers significant insights into recruitment and enrollment, enabling clinical trials to progress more swiftly and with improved predictability. By cutting out unnecessary tasks, sites can redirect their focus on what is truly important: supporting patients. Effortlessly oversee recruitment across various trials, sponsors, or CROs by entering information just once, ensuring it reaches the appropriate channels. This revolutionary strategy not only simplifies the process but also fosters enhanced collaboration among all parties engaged in clinical trials, ultimately contributing to more efficient research outcomes. With such an innovative approach, we are redefining the standards for success in the clinical trial process.

CTMS Master stands out as the leading clinical trial management system, crafted to tackle the intricate technical issues associated with managing clinical trials. By enhancing user communication, minimizing manual tasks, and eradicating redundant data, CTMS Master streamlines the overall trial process. This system not only improves efficiency but also features a Site Visit Report tool that works seamlessly with an automated workflow to avoid any duplicate data entry. Additionally, it simplifies the generation and distribution of ready-to-use Site Visit Reports (SVR). Users can utilize standard templates for various documents related to sites and projects, including budgets, events, milestones, and reports on site visits. With CTMS Master, you gain access to over 100 metrics and statistics designed to monitor clinical study sites, countries, and projects effectively. Furthermore, it comes equipped with more than 80 standard reports and offers ad-hoc reporting options for customized insights. Users can also develop site-specific budgets based on a default template, track both accrued and future obligations, and establish either automatic or manual approval processes for each payment type, ensuring thorough financial oversight throughout the trial. This comprehensive approach not only enhances transparency but also fosters better decision-making in clinical trial management.

In the field of clinical research, meticulous organization is crucial for achieving effective outcomes. The challenge of deploying the right resources at the right time becomes particularly pronounced when it comes to managing documents during a clinical trial. GRAVITY has emerged as a trusted solution for overseeing site files and trial master files. We have reimagined these documents into an accessible and unified electronic format, which significantly improves document management by offering a structured and practical system. Acting as an integrated eTMF and eISF platform, GRAVITY functions as a comprehensive cloud-based Document Management System (DMS), serving as a central hub for sponsors, contract research organizations (CROs), and research sites. Additionally, GRAVITY can be utilized independently by each stakeholder when required. As soon as a site is selected for a clinical trial, there is a surge of incoming documents that need to be managed with precision. GRAVITY incorporates a unique feature that tracks vital document management while alerting users to any documents approaching their expiration dates, thereby promoting compliance and operational efficiency throughout the trial. This forward-thinking strategy not only simplifies processes but also significantly elevates the overall quality of clinical research initiatives. Ultimately, GRAVITY stands as a testament to the advancements in document management technology within the clinical research landscape.

Koneksa has emerged as a leading digital biomarker company, serving the pharmaceutical and biotechnology industries with a focus on the development, evaluation, and validation of digital biomarkers that help clients understand the impact of treatments on patients. Founded in 2013, Koneksa offers extensive support for remote clinical trials by merging digital health innovations with therapeutic expertise and efficient, user-friendly remote data collection to improve insights into patient health outcomes. Their advanced and validated data algorithms are tailored for immediate application in treatment development, allowing for quicker identification of signals compared to traditional techniques. The company's cloud-based Software as a Service (SaaS) platform supports real-time integration of various endpoints, granting immediate data access and facilitating informed, cost-effective decisions early in the trial stages. Furthermore, the platform's ability to collect significant remote data at higher frequencies opens doors for acquiring ecologically valid measures, which can reduce the required sample size without compromising research integrity. As Koneksa continuously enhances its methodologies and tools, it seeks to transform the approach to clinical trials, ultimately leading to more efficient and patient-centered research practices. This commitment to innovation positions Koneksa at the forefront of a rapidly evolving landscape in clinical research.

Traditionally, the oversight of clinical trials at investigator sites has been a burdensome process, reliant on either the management of multiple shared spreadsheets or the high costs associated with software that often lacked relevance to the Australian setting. MAISi marks a significant advancement in this domain. Initially developed in 2001 as a data repository for clinical trials at a leading hospital, MAISi has evolved into a sophisticated workflow application aimed at optimizing various functions within research units. Acting as a centralized information hub, MAISi organizes data related to studies alongside the business units responsible for their management. This organized framework enhances the decision-making processes for management. Team members within each unit can access relevant information concerning their specific studies, patients, investigators, and study teams, while those with elevated access rights, such as Financial Officers and System Administrators, have the ability to retrieve detailed information across all units. Moreover, this efficient access not only fosters collaboration but also significantly boosts overall operational effectiveness, making MAISi an indispensable tool in modern clinical trial management. With its user-friendly design and tailored functionalities, MAISi is poised to redefine how clinical research is conducted in Australia.

Improve the efficiency of regulatory operations within your organization to strengthen compliance and promote research progress. Veeva SiteVault streamlines the management of clinical trials by consolidating regulatory responsibilities, resulting in heightened effectiveness and adherence to necessary regulations. You can manage regulatory and source documents through a single platform that meets 21 CFR Part 11 and HIPAA requirements. With real-time data across all trials, SiteVault Enterprise enhances operational performance, speeds up study initiation, and supports rapid, high-quality trial management. Move away from manual processes and personalize your workflows to improve both quality and speed in study activation. By providing monitors with secure, direct access to your regulatory and source documents, you eliminate the complications associated with EMR access and document redaction. Additionally, you can customize your workflows, create reports, and develop dashboards that offer valuable insights into start-up timelines and regulatory processes, ultimately driving improved results for your clinical trials. This holistic strategy not only simplifies processes but also fosters greater collaboration among teams, enabling better communication and efficiency throughout the trial phases. As a result, your organization can achieve its research goals while maintaining rigorous compliance standards.

Clinical Conductor CTMS is an advanced platform designed for the effective management of clinical trials. It caters to a variety of users including hospitals, research facilities, and asset management firms, as well as site networks, health systems, and contract research organizations (CROs). By utilizing this cloud-based solution, clinical trials can be executed with greater efficiency, enabling research organizations to enhance their decision-making processes. Notable features of this system encompass electronic data capture, enrollment management, document control, and recruitment oversight, among others, providing a comprehensive toolkit for trial management. Ultimately, it streamlines operations and fosters improved outcomes in clinical research endeavors.

Replior stands out as an innovative company that focuses on delivering advanced software solutions tailored for clinical trials, featuring a comprehensive platform that integrates EDC, eConsent, ePRO, and Virtual Visits to optimize trial execution. Our all-encompassing system, known as Trial Online, streamlines the collection and management of data from researchers, participants, and wearable technology efficiently. It is meticulously designed to support decentralized clinical trials (DCT), providing the flexibility to accommodate site visits, remote interactions, or a blend of both. Our journey began two decades ago when we were tasked with developing an online CRF service for a prominent pharmaceutical company, which marked our evolution from an IT operations provider into a specialized software developer focused on clinical data collection. Over time, we have broadened our offerings to provide a full range of data collection services, while our IT operations are adeptly overseen by our highly skilled sister company, Complior. As we forge ahead, our unwavering commitment to innovating and improving clinical trial processes remains central to our purpose, driving us to continually enhance user experience and data integrity in the trials we support.

Science 37 is an innovative clinical research organization that specializes in decentralized clinical trials using its unique Metasite model, which removes the necessity for physical locations, enabling patients to participate in studies from nearly any location. This approach significantly increases accessibility, allowing over 90% of individuals who may typically be excluded from traditional site-based research to take part, and it boasts recruitment capabilities similar to those of 20 sites concentrated in one area, providing patients with the flexibility they seek. The Metasite leverages a proprietary platform that simplifies study management and enhances workflow for both patients and research personnel, all while ensuring efficient data capture without the need for manual reentry. By consolidating staff, processes, and technology, this model ensures built-in compliance with protocols, leading to improved adherence rates and the collection of high-quality data. Furthermore, Science 37's committed in-house medical professionals, telemedicine investigators, and mobile nursing teams possess extensive experience in managing remote trials across a wide variety of therapeutic areas, guaranteeing extensive outreach and support. This dedication to pioneering trial methodologies establishes Science 37 as a leader in reshaping the clinical research landscape, thereby opening new avenues for patient engagement and participation.

Longboat is a cloud-based platform tailored to enhance the efficiency of clinical trials, featuring an integrated Guided Compliance toolset that provides ongoing assistance to users throughout the entire process. By equipping clinical trial site personnel with vital resources, Longboat allows them to focus more on patient care. Moreover, participants can conveniently access important study information and receive timely reminders for upcoming visits. The system streamlines the management of protocol amendments, ensuring they are implemented smoothly and effectively. Additionally, Longboat centralizes the secure exchange of regulated documents among sponsors, CROs, and sites, thereby significantly improving the startup process and alleviating the burden of traditionally tedious tasks for all involved in research. With a unified support platform, all primary stakeholders—including clinical operations teams, monitors, site staff, and trial participants—can access tailored content that meets their specific needs. This holistic strategy guarantees that site staff are well-equipped with the necessary tools and resources to stay engaged and compliant while maintaining a strong focus on participant welfare. In this manner, Longboat not only enhances operational efficiency but also significantly enriches the overall experience for everyone participating in the clinical trial, fostering a more collaborative and effective research environment. By prioritizing user needs, Longboat paves the way for innovative solutions in clinical research management.

Deep 6 AI transforms the patient enrollment landscape for clinical trials by innovatively altering the methods researchers use to locate appropriate candidates. Utilizing cutting-edge artificial intelligence and natural language processing, DEEP 6 AI adeptly navigates through both structured and unstructured patient data, allowing for the rapid identification of a broader range of well-suited trial participants in just minutes, a stark contrast to the months traditionally required. The platform works in conjunction with prominent health systems, pharmaceutical firms, and contract research organizations, establishing itself as a pivotal element of the clinical research framework and significantly accelerating patient access to trials. Beyond just speeding up enrollment, Deep 6 AI’s groundbreaking software analyzes structured data, such as ICD-10 codes, alongside unstructured clinical information like physician notes, pathology reports, and surgical documents, which can often be challenging to sift through. This thorough examination guarantees that researchers can swiftly locate candidates who fulfill specific requirements, thereby facilitating a quicker rollout of innovative treatments for those in need. Consequently, the integration of this technology not only enhances the efficiency of trial processes but also holds the potential to transform patient care by ensuring timely access to life-saving therapies.

Advancing artificial intelligence to eliminate the necessity for trial and error in healthcare, our digital twins enable rapid and reliable clinical trials. We prioritize research in fields such as neuroscience, immunology, and metabolic disorders, among others. TwinRCTs accelerate full enrollment by requiring fewer participants to achieve the same statistical power as traditional trial methods. This innovative strategy drastically cuts down on the time needed for late-stage study enrollment. Furthermore, TwinRCTs improve the detection of treatment effects in early-stage research by increasing statistical power without needing more participants. They allow researchers to make well-informed decisions based on initial findings and assist in attracting additional participants to clinical trials. By utilizing smaller control groups, TwinRCTs also enhance the likelihood of participants receiving the experimental treatment. Our dedication to ensuring that clinical trials with digital twins achieve regulatory approval remains steadfast. Unlearn is leading the charge in revolutionizing the healthcare industry through the pioneering use of artificial intelligence, crafting and applying cutting-edge generative models that utilize extensive datasets gathered from prior patient studies. This shift in methodology not only optimizes research efficiency but also significantly improves the effectiveness of clinical trials. The future of medicine is being reshaped as we continue to refine these innovative approaches.

Discover the leading edge of eSource, CTMS, and eRegulatory software tailored for clinical trial sites with CRIO. Our premier electronic source enables you to capture source data in real-time, significantly reducing paper dependency by up to 90% and improving data quality by 80%. Take control of your operations with CRIO’s intuitive Clinical Trial Management System, which streamlines patient scheduling, financial oversight, and recruitment optimization. We proudly offer innovative electronic regulatory binders, featuring the groundbreaking first-ever electronic delegation log, all fully compliant with 21 CFR Part 11 regulations. For sponsors of clinical trials, our secure online portal allows for complete remote monitoring of your sites’ source data and regulatory documents. Join our vast network of over 500 clinical research sites globally, and benefit from our dedication to enhancing your business by simplifying your site operations. This ensures that your studies progress seamlessly, whether you are on-site or working remotely, allowing you to concentrate on what truly matters: propelling your clinical research efforts forward while ensuring efficiency and accuracy throughout the process.

EasyTrial.net is a versatile online platform that provides you with the ability to access study data at your convenience, regardless of your location. This innovative system facilitates collaboration by offering tailored access controls, allowing you to selectively share certain information while limiting access to other sensitive data as required. Furthermore, EasyTrial.net is compliant with GDPR standards, guaranteeing the secure storage of your data. As the lead investigator, you retain full authority over your data, while EasyTrial.net serves as the data processor, prepared to finalize data handling agreements whenever necessary. Our specialization in data security is underscored by our strong focus on IT and cybersecurity measures. Throughout the years, a multitude of clinical trials has been successfully managed using EasyTrial.net, which has garnered the trust and endorsement of various data regulation authorities, hospitals, and educational institutions worldwide, highlighting the platform's reliability and security. This vast experience not only demonstrates our capability but also bolsters our dedication to protecting your sensitive information throughout the entirety of the research process, ensuring peace of mind as you navigate your studies.

Our top-tier solution for overseeing patient randomization and trial supplies is offered in multiple formats, making it the most versatile and customizable Interactive Response Technology available today. Whether you're engaged in Phase I through Phase IV trials, and regardless of the complexity of your study design—be it simple or involving sophisticated adaptive methods—IXRS®3 is designed to accommodate any mix of study objectives. You will also have the advantage of a dedicated team of biostatisticians and integration specialists available 24/7 to assist you. The functionalities designed for site users enhance workflows that are usually prone to human error, enabling them to amend data independently without the need to reach out to a Help Desk or worry about compliance challenges. Instead of navigating through extensive pages filled with specifications and legal language, users can utilize intuitive visual tools that improve clarity. Moreover, you can keep track of and react to each phase of the software development process, which helps mitigate unforeseen issues during implementation, ensuring a more seamless trial experience. This holistic approach not only boosts operational efficiency but also grants users greater authority over their trial methodologies. Ultimately, this empowers research teams to conduct their trials with confidence and precision.

Medable provides a cutting-edge software platform tailored for the research and execution of clinical trials in a decentralized manner. This innovative technology is designed to engage patients remotely, ensuring the accuracy of data collection. Moreover, patients have the ability to give their consent for digital assessments from their own locations, while the platform adapts to various local languages and regulatory standards. You can optimize your protocol’s decentralization through our flexible, modular digital and decentralized clinical trial (DCT) platform, enabling extensive remote screening across the globe to meet your enrollment targets more efficiently. Create customized screening assessments that address your specific requirements, and improve the clarity of consent documents with responsive designs that work seamlessly on both web and mobile devices. Our remote eConsent experiences provide patients with a user-friendly interface akin to popular consumer applications. With our platform’s adaptability to local laws and languages, we ensure global flexibility to cater to a wide range of needs. By actively involving patients and minimizing the challenges tied to travel and scheduling for on-site visits, we significantly enhance patient access and engagement in the research study. This method not only streamlines the clinical research process but also emphasizes the importance of patient convenience and participation, ultimately fostering a more inclusive and effective research environment. In doing so, Medable redefines the way clinical trials are conducted, paving the way for a more patient-centered approach to medical research.

Select Curebase for your next research project and benefit from increased diversity, faster enrollment, and better patient retention. Our cutting-edge approach allows patients to engage from their homes with the backing of local physicians, leading to swifter, more affordable, and inclusive research endeavors. The unique synergy between our in-house virtual Clinical Research Coordinators (CRCs) and a global network of virtual Principal Investigators (PIs) ensures that studies are brought directly to patients, regardless of their geographical location. Many individuals live far from traditional research sites; thus, our trials are designed to effectively integrate research into their daily lives and local healthcare settings, such as nearby doctor's offices. Curebase's innovative model for infectious disease studies captivates patients by aligning with their preferences and utilizing both community healthcare and virtual spaces, which broadens participation in critical clinical trials. By harnessing technology and fostering local relationships, Curebase not only increases accessibility but also elevates the entire research experience for both patients and healthcare providers. This commitment to innovation reflects our dedication to transforming the landscape of clinical research for the better.

Data is sourced from multiple avenues such as EDC, EHR, smartphones, mobile devices, and central laboratories. Prism adeptly assimilates this varied data and converts it into actionable insights. By fusing user-friendliness with state-of-the-art features, Prism EDC offers a contemporary method for the collection and management of clinical trial data. In addition to conventional form-based data collection, Prism also aggregates and organizes information from a myriad of sources. Moreover, Prism eSource introduces a revolutionary software solution that allows research teams to directly extract clinical trial data from a site's electronic health record (EHR). This advancement not only boosts efficiency and cuts costs when compared to the previous model—where sites had to repetitively enter the same data into various systems—but also accelerates the process of making new therapies available to patients in need. Consequently, the healthcare sector stands to gain immensely from the efficient processes that Prism enables, ultimately improving patient outcomes and enhancing the quality of care.

Clin'form is a robust and flexible electronic Clinical Outcome Assessment (eCOA) platform designed to enhance the efficiency of clinical trials for both participants and research facilities, while also improving data accuracy and expediting processes for research teams. Its adaptability allows it to be utilized across a wide array of protocols and demographics, making it ideal for any questionnaire type, including Patient-Reported Outcomes (PRO), Observer-Reported Outcomes (ObsRO), Clinician-Reported Outcomes (ClinRO), and diaries, catering to a diverse demographic from children to seniors. The platform is engineered to accommodate varying population sizes, effectively managing studies that involve small cohorts as well as those with more than 10,000 participants across multiple global locations. Clin'form seamlessly integrates with other clinical systems to create an efficient workflow, supporting a range of data collection methods—including dedicated tablets, smartphones, patients' personal devices, web access via any browser, and in-person interviews. A standout feature is the integrated tele-visit option, which provides flexibility in response to unforeseen changes, along with patient engagement tools that are designed to foster high compliance rates. Furthermore, the intuitive interface of Clin'form ensures that both researchers and participants can navigate the platform with ease, thereby enhancing the overall clinical trial experience and effectiveness. Overall, Clin'form not only streamlines the data collection process but also places a strong emphasis on user experience, making it a valuable asset in clinical research.

Clinpal is recognized as the leading all-in-one clinical research platform tailored for virtual, hybrid, and direct-to-patient studies. This innovative platform allows patients to connect from any location using a variety of devices, enhancing both convenience and accessibility. Research teams benefit from extensive data and analytics capabilities throughout the entire trial process, while sites enjoy the advantages of having all essential features integrated into a single, user-friendly system, effectively reducing their workload. With Clinpal Build, users can take advantage of an intuitive point-and-click interface, enabling Contract Research Organizations (CROs) and others to quickly and easily set up data, forms, and workflows. The platform's Single Platform feature fully supports clinical trials by covering every aspect, from patient recruitment and data capture to long-term follow-up, ensuring data availability as required. Moreover, Clinpal employs advanced technology that accommodates various formats, allowing for a cohesive online setup; this means that once configured, it functions seamlessly across browsers, mobile devices, or applications. This forward-thinking approach not only simplifies the clinical trial process but also fosters greater engagement from researchers and participants, leading to more efficient study outcomes. Additionally, Clinpal’s commitment to innovation keeps it at the forefront of clinical research advancements, continuously improving user experience and study efficiency.

Cloudbyz CTMS is a cloud-based clinical trial management solution built on the Salesforce Cloud platform, specifically designed for sponsors, clinical research organizations (CROs), and clinical sites to oversee the entire spectrum of clinical trial operations. This platform is tailored for the clinical research field, facilitating swift implementation and fostering user engagement. With its user-friendly and clear interface, Cloudbyz CTMS enables rapid deployment, ensuring that teams can hit the ground running. Equipped with a comprehensive array of features, it simplifies the management of all facets of clinical trials, encompassing site management, participant enrollment, documentation, event tracking, milestone monitoring, site visit reports, financial oversight, and inventory control. The advantages of using Cloudbyz CTMS include the following: 1. A secure, reliable, and scalable infrastructure 2. Accelerated realization of value 3. The ability to track study progress and potential risks from the planning stage through to closure 4. Enhanced collaboration among sponsors, CROs, and clinical sites 5. Boosted efficiency for clinical research teams 6. Overall, the platform significantly enhances the clinical trial process, making it more streamlined and effective.

The Trialpack Designer is an intuitive yet powerful software application tailored for the creation of blister packs and cards intended for clinical trials. It is particularly adept at designing packaging for complex blinded studies, such as those involving dosage titrations, double-dummy configurations, and cross-over trials, where a single package might include multiple items. The application effortlessly supplies essential configuration data for the Trialpack PC Controller, Controlled Dosing Systems, and Robotic Packaging Systems. Users can conveniently create various blister shapes, print images, and filling patterns directly from the interface. Moreover, it incorporates detailed user access controls, streamlines workflows with electronic signatures, and maintains a thorough audit trail in adherence to 21 CFR Part 11 regulations. The system also produces reports that offer comprehensive packaging instructions alongside a detailed inventory of material needs, which ensures meticulous documentation and compliance for trial activities. This versatile tool plays a vital role in preserving the integrity and organization of clinical trial packaging, ultimately contributing to the success of the trials conducted. Furthermore, its user-friendly design makes it accessible for professionals at all levels, enhancing collaboration and efficiency throughout the research process.

Efficiently oversee every phase of clinical trials with Ennov’s all-inclusive Clinical Trial Management software. Each year, sponsors of clinical trials seek innovative strategies to enhance efficiency and minimize the expenses tied to their operations. By centralizing data, consistently tracking advancement, automating timelines, overseeing budgets, and delivering precise reporting and metrics, investigational site productivity can be significantly boosted. Ennov CTMS empowers trial sponsors and Contract Research Organizations (CROs) to manage all facets of trial operations from a unified platform, including investigator sites, participants, serious adverse events, deviations, inclusions, visit documentation, communication with trial subjects, management of investigational products, trial locations, and financial oversight. Study managers can monitor and plan their trials in real-time, enabling quicker and more informed decision-making. Additionally, the dashboard features of Ennov CTMS provide study teams with immediate access to analytics, enhancing quality, mitigating risks, and curtailing costs further. This comprehensive approach ultimately leads to a more streamlined clinical trial process, fostering greater success rates.

In the past, clinical trials and medical research were typically conducted in isolation from the everyday care provided by local healthcare providers and individual practitioners. As a result, many doctors were often unaware of the research efforts underway, leaving their patients in the dark about potential studies that could improve their health outcomes. Elligo has revolutionized this scenario by enabling greater involvement in clinical research through access to an extensive network of over 150 million patients and their detailed data, which allows physicians to introduce research opportunities to patients who might not have otherwise been aware of them. The conventional participant recruitment methods frequently encounter obstacles, including the necessity for patients to travel to designated research locations, which can hinder participation rates. Furthermore, research suggests that patients are more likely to engage in studies when these initiatives are associated with their familiar healthcare providers, highlighting the critical need for the integration of clinical research within established medical settings. By adopting this innovative approach, not only do we bridge the divide between research and patient care, but we also empower individuals to actively engage in meaningful medical advancements that could potentially change their lives. This integration fosters a collaborative environment where patients feel more supported and informed about their treatment options.

Improve the robustness of your evidence by utilizing advanced electronic Patient-Reported Outcomes (ePRO) and electronic Clinical Reported Outcomes (eClinRO). These electronic assessments, collectively referred to as eCOA, effectively capture patients' emotions and functional capabilities during clinical trials. By adopting an electronic approach to clinical data collection, you ensure that the information gathered from patients is not only of superior quality but also adheres to necessary regulatory guidelines. Essentially, eCOA addresses the pitfalls associated with traditional paper diaries, such as readability issues, transcription errors, and data inconsistencies. Moreover, the FDA encourages the implementation of ePRO, which allows patients to express their health experiences through various questionnaires, potentially covering aspects like quality of life and daily activity levels. Conversely, clinician-reported outcomes involve assessments conducted by healthcare professionals, including evaluations such as physical examinations like the Psoriasis Area and Severity Index (PASI). Additionally, performance outcomes assess a patient's capability to perform specific tasks, including timed activities, thereby providing a holistic perspective on their health. In conclusion, embracing eCOA and its related strategies represents a significant advancement toward enhancing the reliability and efficiency of clinical trial methodologies, ultimately benefiting patient care. This shift not only streamlines data collection but also fosters greater patient engagement in their health management.

Explore the latest advancements in collecting clinical and patient-reported outcomes data. Our all-encompassing solution goes beyond simple data recording, aiming to create a truly patient-centered research journey. Our eCOA software, built on the foundations of behavioral science, has been meticulously crafted by healthcare experts to cater to the demands of both research sites and sponsors. By focusing on individual identity, motivational triggers, and key goals, we differentiate ourselves from other eCOA platforms. The Datacubed app is designed with an intuitive interface, enabling participants to easily engage with essential elements. It has been noted that the process of data collection is now more efficient than ever, thanks to our flexible, user-friendly, and interactive application. As the necessity for adaptable trial designs becomes increasingly prominent, we offer a range of versatile data collection methods that can be conducted in-person, remotely, or through a hybrid model, accommodating the varied needs of conventional, hybrid, and virtual clinical studies. This level of flexibility guarantees that researchers can capture the most pertinent data, irrespective of the format of the trial. Furthermore, our commitment to continuous improvement ensures that we remain at the forefront of innovation in the field.

Complion's platform caters specifically to the needs of clinical researchers. Our innovative solution guarantees top-tier compliance while minimizing effort and maximizing efficiency. This enables you to focus on what truly matters: enhancing and advancing patient outcomes effectively. Our eReg solution is accessible to all parties involved in clinical trials, including Sponsors, Research Sites, and CROs. By utilizing our platform, you can lower costs, prevent redundancy, and boost staff productivity. The ability to easily archive, view, and obtain signatures from any device is a key feature. Furthermore, an integrated audit trail is designed to ensure precision and mitigate risks related to patient safety and study execution. We proudly serve a diverse clientele that includes hospitals, cancer care facilities, medical centers, multi-specialty clinics, and dedicated research sites, highlighting the platform's versatility and reliability. This comprehensive approach not only streamlines processes but also fosters collaboration among all stakeholders involved in clinical research.

Mahalo Health is a comprehensive digital health platform designed to accelerate the development of patient-centered digital health solutions and clinical trials. It offers an array of prebuilt modules that enable the rapid deployment of customizable white-label applications tailored to specific therapeutic areas. The platform is equipped with advanced data capabilities, which include a predictive health engine for anticipating diseases and diagnoses, a behavior modification engine that promotes healthy patient habits, and a notification system that guarantees prompt communication via push notifications, SMS, or emails. Mahalo Health is dedicated to upholding rigorous security and compliance standards, adhering to regulations like HIPAA, GCP, ISO27001, and GDPR. Its diverse service offerings span various therapeutic domains, such as diabetes management, cognitive health, cardiovascular care, musculoskeletal issues, mental well-being, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Furthermore, Mahalo Health not only enhances patient engagement but also improves health outcomes by equipping healthcare providers with innovative digital tools and solutions that adapt to the evolving needs of their patients. This commitment to innovation ensures that healthcare delivery is both efficient and personalized.

Improve data management quality by capturing eSource data directly during patient encounters. This method includes integrated editing and validation features that enable users to collect high-quality information electronically, significantly reducing errors and inquiries while allowing for real-time remote monitoring. As a result, the overall duration, costs, and risks associated with studies are noticeably decreased. Approved by the FDA, this cutting-edge eSource method streamlines and modernizes the clinical trial process, effectively replacing traditional, error-prone monitoring and the manual transcription into electronic data capture (EDC) systems. Furthermore, designed with site users in mind, ez-SourceDocx enhances workflows, lightens workloads, and ensures compliance with study protocols by guiding sites through properly sequenced visit procedures, which not only guarantee the collection of all endpoint data but also promote timely quality evaluations by investigators. This all-encompassing system ultimately bolsters the efficiency and dependability of clinical trials while paving the way for innovations in data management practices. By leveraging technology in this manner, the potential for improved patient outcomes increases significantly.

At ePharmaSolutions, we are at the forefront of developing groundbreaking strategies. Although we do not consider ourselves a high-tech corporation, our core is founded on concepts that are intricately linked to technology yet not limited by it. We are transforming the drug development sector by providing solutions that optimize the processes of identifying, activating, training, and managing clinical trial sites. By reinterpreting conventional challenges through a fresh perspective, we deliver technology-enhanced solutions aimed at simplifying the complexities associated with clinical trial management. ePharmaSolutions (ePS) distinguishes itself as a leading provider of e-clinical solutions that revolutionize the processes of selecting, training, activating, and managing clinical trial sites. By introducing innovative viewpoints to persistent challenges, we develop advanced, technology-driven solutions that empower sponsors, contract research organizations, and investigator sites to efficiently tackle and streamline the complexities of clinical trial management. Our dedication to transforming these processes guarantees that we stay at the cutting edge of the industry, consistently evolving to address changing demands, ultimately fostering a more efficient and effective clinical trial landscape.

The Medidata Clinical Cloud is an advanced platform crafted to transform the clinical trial experience for patients, sponsors, CROs, and research institutions alike. As the only all-encompassing technological solution dedicated solely to clinical research, this platform covers the entire spectrum of research from its initial stages to final outcomes. It empowers organizations within the life sciences and medical device industries to cut down on development costs, effectively manage risks, and accelerate the launch of new treatments and devices into the market. Regardless of your choice for clinical trial strategies, the advantages of the Medidata Clinical Cloud will be at your disposal. Medidata stands at the leading edge of the digital transformation in clinical research. By harnessing the capabilities of artificial intelligence, machine learning, and advanced analytics, our platform facilitates connections among researchers, study coordinators, investigators, and patients, ultimately speeding up the research process. Furthermore, it features a regulatory-compliant and patient-centric electronic informed consent solution for clinical trials, which improves the experience for everyone involved. This seamless integration of cutting-edge technology not only optimizes operational efficiency but also significantly uplifts the overall quality and integrity of clinical research endeavors. Thus, adopting the Medidata Clinical Cloud means embracing a future where clinical trials are more efficient and patient-focused than ever before.

Electronic source documents, commonly referred to as eSource, eliminate the necessity for physical paperwork, improve workflows, and significantly reduce the likelihood of mistakes and omissions. The BREEZE eSource platform goes beyond mere visit templates and scheduling capabilities. By integrating clinical settings with regulatory and protocol requirements as well as study-specific procedures, BREEZE eSource ensures that users efficiently collect all necessary data dictated by the protocol. Moreover, BREEZE’s array of business rules guarantees that the information obtained is precise, complete, and in compliance with established standards. Our dedicated team of clinical trial experts creates customized, study-specific eSource documents that are meticulously reviewed and approved before the study begins, with ongoing assistance and modifications provided throughout the duration of the trial. The various modules work together harmoniously and are designed for seamless integration. Additionally, the Cross-Module Action Multiplier not only boosts efficiency by anticipating needs but also automates supplementary tasks triggered by user input, such as promptly updating invoicing for completed visits or procedures and recalibrating the schedule as required. This thorough approach not only streamlines the process but also significantly bolsters data integrity and enhances operational effectiveness, ultimately leading to more successful clinical trials. In a landscape where efficiency and accuracy are paramount, BREEZE eSource stands out as an indispensable tool for modern clinical research.

Clinion RTSM simplifies the management of clinical trial supplies and patient randomization through the use of Interactive Response Technologies (IWRS). The Inventory module seamlessly connects with the Randomization module of Clinion RTSM Software, enabling the execution of both straightforward and intricate randomization strategies tailored to protocol requirements. Recognized as one of the leading integrated EDC/RTSM platforms in the market, Clinion allows site users to manage randomization, drug allocation, returns, and reallocation without the need to log into multiple systems or concern themselves excessively with reconciliation. Our straightforward and cost-effective pricing structure helps reduce the overall expenses associated with RTSM ownership, ensuring that quality and functionality are maintained. By combining EDC and RTSM modules, you can enhance operational efficiency and maximize the benefits of your clinical trial management processes.

ClinEdge is transforming the landscape of clinical trials by providing a comprehensive suite of services tailored for Sponsors, CROs, and Sites. We utilize innovative and collaborative strategies to tackle the various challenges our clients face throughout the process. Our unwavering commitment to improving trial outcomes encompasses all phases of each study, ensuring that both Sponsors and CROs benefit from enhanced Site and Patient Access, while also delivering superior Trial Solutions to our Site partners. With over a decade of experience in the industry and a deep understanding of our clients' needs, ClinEdge is dedicated to redefining how studies are executed, ultimately leading to more efficient and effective clinical trials. Our goal is not only to innovate but also to establish new benchmarks within the clinical trial industry, fostering a culture of excellence and reliability. As we continue to grow and adapt, we remain focused on delivering exceptional value to our partners and stakeholders.

SimpleTrials is a subscription-driven, on-demand Clinical Trial Management System (CTMS) tailored for sponsors, Contract Research Organizations (CROs), and research sites. It encompasses a wide array of tools designed to efficiently plan, oversee, and monitor clinical study portfolios, featuring capabilities such as site initiation and subject monitoring, document management through an integrated electronic Trial Master File (eTMF), real-time analytics for studies, comprehensive calendars and monitoring options, customizable fields and trackers, on-demand reporting, planning milestones, management of site contracts and payments, as well as electronic visit documentation. The platform is built to ensure compliance with 21 CFR Part 11 and establishes a secure, validated space for handling clinical trial data. Users benefit from the ability to personalize tracking views, connect with various Electronic Data Capture (EDC) systems, and access pre-built templates for uniform document management. Furthermore, the system enhances collaboration among stakeholders, facilitating smoother communication throughout the trial process.

Accelerating the development of essential drugs while guaranteeing equitable access to high-quality cancer therapies and research for patients globally is paramount. Our innovative technology is revolutionizing patient access to state-of-the-art medications and participation in clinical trials. FICS represents a pioneering software solution that streamlines the collection of regulatory-compliant data during patient treatment. By unifying disparate and previously disconnected applications into a cohesive and efficient platform, FICS enhances the speed and quality of clinical trials, which significantly improves patient outcomes. This transformative approach not only simplifies the trial process but also fosters better collaboration among researchers and healthcare providers.

Korio stands out as a multifunctional platform for Randomization & Trial Supply Management (RTSM), prioritizing flexibility, exceptional quality, and operational efficiency. Its design is not only reactive to clinical trial challenges but also anticipates and mitigates potential issues before they materialize. No matter the complexities of the trials faced, Korio is capable of effectively overseeing them. Many conventional RTSM systems find it difficult to navigate the increasing intricacies of study designs, while rigid platforms are often unable to implement essential RTSM design changes quickly when clinical trials evolve. Leveraging a wealth of practical experience, Korio has developed an RTSM solution that harmonizes adaptability with reliability, merging cutting-edge innovation with deep-rooted expertise. By utilizing Korio’s intuitive, role-specific interface, a wide array of users—including site personnel, supply managers, and clinical operations and data management teams—can enhance their productivity and perform their tasks with greater assurance. With Korio, you are guaranteed a consistently managed trial experience that remains responsive to your changing requirements. In conclusion, Korio transcends being merely a tool; it is a holistic solution tailored for the complexities of contemporary clinical trial management, ensuring that all stakeholders can achieve their goals seamlessly.